APPENDIX I

ACCOUNTANTS’ REPORT

Name of Company

Notes

Incorporation

Incorporation

Place of

Date of

Percentage of
Ownership by
the Company

Principal Activities

BeiGene Pharmaceutical (Shanghai) Co.,

(h)

PRC

December 15, 2009

100% Medical and

Ltd. (“BeiGene Pharmaceutical
(Shanghai)”)

pharmaceutical
consulting,
marketing and
promotional services

BeiGene Switzerland GmbH (“BeiGene

(c)

Switzerland

September 1, 2017

100% Research,

Switzerland”)

BeiGene Ireland Limited

(c)

Republic of Ireland

August 11, 2017

development,
manufacturing, and
commercial
activities

100% Clinical trial

activities

*

Wholly-owned by BeiGene Biologics

Notes:

(a)

The statutory financial statements of BeiGene (Hong Kong) Co., Limited for the year ended December 31, 2016 prepared
under Hong Kong Financial Reporting Standards (“HKFRSs”) were audited by Peter Lam & Co., certified public
accountants registered in Hong Kong, and the audited statutory financial statements for the year ended December, 31
2017 prepared under HKFRSs were audited by Ernst & Young, certified public accountants registered in Hong Kong.

(b)

The statutory financial statements of BeiGene (Beijing) Co., Ltd. for the year ended December 31, 2016 and 2017
prepared under PRC Generally Accepted Accounting Principles (“PRC GAAP”) were audited by 北京中誠恒平會計師事
務所有限公司, certified public accountants registered in the PRC.

(c)

No audited financial statements have been prepared for these entities for the years ended December 31, 2016 and 2017.

(d)

(e)

(f)

(g)

(h)

The statutory financial statements of BeiGene (Suzhou) for the year ended December 31, 2016 and 2017 prepared under
PRC GAAP were audited by Zhonghui Certified Public Accountants LLP, certified public accountants registered in the
PRC.

The statutory financial statements of BeiGene Biologics for the year ended December 31, 2017 prepared under PRC
GAAP were audited by Ernst & Young Hua Ming LLP, certified public accountants registered in the PRC.

No audited financial statements of BeiGene (Shanghai) have been prepared under PRC GAAP for the year ended
December 31, 2016, and the statutory financial statements for the year ended December 31, 2017 prepared under PRC
GAAP were audited by Zhonghui Certified Public Accountants LLP, certified public accountants registered in the PRC.

The statutory financial statements of BeiGene Guangzhou Factory for the year ended December 31, 2017 prepared under
PRC GAAP were audited by Ernst & Young Hua Ming LLP, certified public accountants registered in the PRC.

The statutory financial statements of BeiGene Pharmaceutical (Shanghai) for the year ended December 31, 2016 prepared
under PRC GAAP were audited by KPMG Huazhen LLP Shanghai Branch, certified public accountants registered in PRC,
and the statutory financial statements for the year ended December 31, 2017 prepared under PRC GAAP were audited
by Ernst & Young Hua Ming LLP, certified public accountants registered in the PRC.

— I-15 —

